Clinical profile, common thrombophilia markers and risk factors in 85 young Indian patients with arterial thrombosis
Keywords:
Thrombophilia, Myocardial infarction, Stroke, Fibrinogen, Lipoprotein(a)Abstract
CONTEXT AND OBJECTIVE: Arterial thrombosis may occur consequent to hereditary thrombophilia and increased lipoprotein(a) [Lp(a)] and fibrinogen. Our aim was to study the prevalence of common thrombophilia markers in 85 consecutive cases of arterial thrombosis. DESIGN AND SETTING: A retrospective study was conducted from 85 consecutive young patients treated as outpatients or admitted due to stroke or myocardial infarction at a tertiary care hospital. METHODS: Eighty-five Indian patients (age < 45 years) presenting ischemic stroke (n = 48) or myocardial infarction (n = 37) and 50 controls were studied for seven thrombophilia markers including antithrombin (AT), factor V, protein C, protein S, activated protein C resistance (APC-R), fibrinogen and Lp(a). Functional assays for protein C, protein S, factor V and APC-R were performed using clotting-based methods. Semiquantitative estimation of fibrinogen was done using Clauss’s method and Lp(a) using immunoturbidimetry. Statistical analysis was done using the Epi Info 6 software. RESULTS: Thirty-three samples (38.8%) tested positive for one or more thrombophilia markers. The three commonest abnormalities were elevated Lp(a) (20%), fibrinogen (17.6%) and low APC-R (14.2%). Low levels of protein C, protein S and AT were present in 4.7, 9.4 and 7% of the patients, respectively. Overall, the risk factor profile was: smoking (33%), positive family history (15.3%), hyperlipidemia (7%), hypertension, diabetes mellitus and obesity (2.3% each). CONCLUSIONS: An association was found between low levels of protein C, protein S and AT and arterial thrombosis, but only elevated fibrinogen levels, smoking, positive family history and hyperlipidemia showed statistical significance.
Downloads
References
Haywood S, Liesner R, Pindora S, Ganesan V. Thrombophilia and first arterial ischaemic stroke: a systematic review. Arch Dis Child. 2005;90(4):402-5.
Segev A, Ellis MH, Segev F, et al. High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. Int J Cardiol. 2005;98(3):421-4.
de Ronde H, Bertina RM. Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation. Blood Coagul Fibrinolysis. 1999;10(1):7-17.
Herrmann W, Quast S, Wolter K, et al. Determination of free apolipoprotein(a) in serum by immunoassay and its significance for risk assessment in patients with coronary artery disease. Clin Chem Lab Med. 1999;37(1):21-8.
Barreirinho S, Ferro A, Santos M, et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol. 2003;28(2):134-8.
Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957;17(4):237-46.
Mishra MN, Bedi VS. Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis. Sao Paulo Med J. 2010;128(5):263-7.
Wolf M, Boyer-Neumann C, Martinoli JL, et al. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost. 1989;62(4):1144-5.
Herrmann FH, Salazar-Sanchez L, Schröder W, et al. Prevalence of molecular risk factors FV Leiden, FV HR2, FII 20210G>A and MTHFR677C>T in different populations and ethnic groups of Germany, Costa Rica and India. International Journal of Human Genetics. 2001;1(1):33-9. Available from: http://www. k republishers.com/02-Journals/IJHG/IJHG-01-0-000-000- 2001-Web/IJHG-01-1-001-075-2001-Abst-PDF/IJHG-01-1-033- 039-2001-Herrmann/IJHG-01-1-033-039-2001-Herrmann.pdf. Accessed in 2012 (Nov 27).
Bhattacharyya M, Kannan M, Chaudhry VP, Saxena R. Venous thrombosis: prevalence of prothrombotic defects in north Indian population. Indian J Pathol Microbiol. 2003;46(4):621-4.
Saxena R, Mohanty S, Srivastava A, Choudhry VP, Kotwal J. Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians. Eur J Haematol. 1999;63(1):26-8.
Khare A, Ghosh K, Shetty S, Kulkarni B, Mohanty D. Combination of thrombophilia markers in acute myocardial infarction of the young. Indian J Med Sci. 2004;58(9):381-8.
Jose J, Selvakumar D, Selvakumar R, Kanagasapabathy L, Jeyaseelan
L. Plasma fibrinogen--an independent risk factor for ischaemic heart disease. Indian Heart J. 1998;50(1):45-8.
Gheye S, Lakshmi AV, Krishna TP, Krishnaswamy K. Fibrinogen and homocysteine levels in coronary artery disease. Indian Heart J. 1999;51(5):499-502.
Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Indian Heart J. 2000;52(4):411-5.
Cicek H, Bayil S, Zer Y, Celik A, Geyikli I. A comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease. Ann N Y Acad Sci. 2007;1100:179-84.
Thaler E, Lechner K. Antithrombin III deficiencyandthromboembolism. Clin Haematol. 1981;10(2):369-90.
Morris JG, Singh S, Fisher M. Testing for inherited thrombophilias in arterial stroke: can it cause more harm than good? Stroke. 2010;41(12):2985-90.
Celik M, Altintas A, Celik Y, Karabulut A, Ayyildiz O. Thrombophilia in young patients with acute myocardial infarction. Saudi Med J. 2008;29(1):48-54.
Ng KW, Loh PK, Sharma VK. Role of investigating thrombophilic disorders in young stroke. Stroke Res Treat. 2011;2011:670138.
